Evidence map›Paper›PMID 21548741›Full record

ArticleRegenerative medicine2011

Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Aileen J Anderson, Daniel L Haus, Mitra J Hooshmand, Harvey Perez, Christopher J Sontag, Brian J Cummings

Abstract read
In one paragraph

Article in Regenerative medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Animal models for the evaluation of retinal stem cell therapies.Progress in retinal and eye research · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A new immunodeficient retinal dystrophic rat model for transplantation studies using human-derived cells.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Aileen J AndersonSue & Bill Gross Stem Cell Center, 845 Health Science Road, UC Irvine, Irvine, CA 92697-1705, USA. aja@uci.edu
Daniel L Haus
Mitra J Hooshmand
Harvey Perez
Christopher J Sontag
Brian J Cummings
UC Irvine Health · USUniversity of California, Irvine · USCalifornia State University, Long Beach · USUniversity of California, Irvine Medical Center · US

Funding

Mechanisms of SCI Recovery after hCNS Stem Cell GraftsR01NS049885 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI ANDERSON, AILEEN J · 2004 to 2008
$1.4M
NINDS NIH HHS R01 NS049885
6 · The paper itself

Abstract

There is potential for a variety of stem cell populations to mediate repair in the diseased or injured CNS; in some cases, this theoretical possibility has already transitioned to clinical safety testing. However, careful consideration of preclinical animal models is essential to provide an appropriate assessment of stem cell safety and efficacy, as well as the basic biological mechanisms of stem cell action. This article examines the lessons learned from early tissue, organ and hematopoietic grafting, the early assumptions of the stem cell and CNS fields with regard to immunoprivilege, and the history of success in stem cell transplantation into the CNS. Finally, we discuss strategies in the selection of animal models to maximize the predictive validity of preclinical safety and efficacy studies.

Indexed as

Stem Cell TransplantationAnimalsCell SurvivalCentral Nervous SystemDisease Models, AnimalGraft RejectionGraft SurvivalHematopoiesisHumansNervous System DiseasesRegenerative MedicineStem CellsTransplantation, Heterologous

Identifiers

PMID21548741
PMCPMC3403688
OpenAlexW1986561732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.